Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TESS V3 Modular Total Shoulder System PMCF

NCT: NCT05002959 · TERMINATED

NCT IDNCT05002959
StatusTERMINATED
Start Date2022-02-01
Completion2026-03-05
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

This is a multicenter, retrospective and prospective, non-controlled post market surveillance study. The objectives of this study are to confirm safety, performance and clinical benefits of the T.E.S.S.® Version 3 Anatomic and Reverse Modular Total shoulder prosthesis and its instrumentation.

Frequently Asked Questions

What is TESS V3 Modular Total Shoulder System PMCF?

TESS V3 Modular Total Shoulder System PMCF is a clinical trial registered under NCT05002959. Current status: TERMINATED.

What is the status of NCT05002959?

The current status of NCT05002959 (TESS V3 Modular Total Shoulder System PMCF) is: TERMINATED.

When did TESS V3 Modular Total Shoulder System PMCF start?

TESS V3 Modular Total Shoulder System PMCF started on 2022-02-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.